Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Active not recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Gastrointestinal 2Breast 2Thoracic 1Sarcoma 1Head & Neck 1Gynecologic 1Dermatologic 1CNS 1

Conditions

Breast Neoplasms 21Prostatic Neoplasms 11Neoplasms 8Head and Neck Neoplasms 8Ovarian Neoplasms 6Oropharyngeal Neoplasms 4Lung Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Sarcoma 3Rectal Neoplasms 3Polycystic Ovary Syndrome 3Pancreatic Neoplasms 3Endometrial Neoplasms 3Carcinoma, Squamous Cell 3Carcinoma, Renal Cell 3Brain Neoplasms 3Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Psychological Well-Being 2Motor Activity 2Melanoma 2Kidney Neoplasms 2Hematologic Neoplasms 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Communication 2Colonic Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Non-Small-Cell Lung 2

Interventions

Nivolumab 37pembrolizumab 26cabozantinib 26Specimen Handling 23Magnetic Resonance Spectroscopy 21Ipilimumab 19lenvatinib 13belzutifan 13Axitinib 13CTLA-4 Antigen 10Sunitinib 9Radiosurgery 8Biopsy 8atezolizumab 7fludarabine 4avelumab 4aldesleukin 4Immunoglobulin G 4Disulfides 4zimberelimab 3toripalimab 3tivozanib 3pazopanib 3palbociclib 3durvalumab 3cemiplimab 3Surveys and Questionnaires 3Nephrectomy 3Everolimus 3Cyclophosphamide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Carcinoma, Renal Cell × Surveys and Questionnaires × 90 days × Clear all
NCT05056077 2026-06-02

TTBF

University of California, San Francisco

Phase NA Active not recruiting
353 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

NCT01624220 2026-05-12

A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy

M.D. Anderson Cancer Center

Phase NA Completed
41 enrolled 8 charts
BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Melanoma, Neoplasms, Unknown Primary, Prostatic Neoplasms, Sarcoma, Spinal Cord Neoplasms, Thyroid Neoplasms

NCT05592665 2026-05-12

PRO-VISION

UNC Lineberger Comprehensive Cancer Center

Phase NA Active not recruiting
42 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡